14 research outputs found
Comparison of prevalence for PCV13 additional serotypes and 6C among different vaccinated groups (PCV 10 vs PCV13).
<p>Comparison of prevalence for PCV13 additional serotypes and 6C among different vaccinated groups (PCV 10 vs PCV13).</p
Pneumococcal NP carriage rate according to demographics and vaccination status.
<p>Pneumococcal NP carriage rate according to demographics and vaccination status.</p
Antimicrobial susceptibility of the 280 isolates among PCV10 serotypes, PCV13 additional serotypes, serogroups, pool only and non vaccines serotypes (NVT).
<p>Antimicrobial susceptibility of the 280 isolates among PCV10 serotypes, PCV13 additional serotypes, serogroups, pool only and non vaccines serotypes (NVT).</p
Number of different serotypes identified among Sp carriers of the cohort.
<p>PCV10 serotypes, PCV13 additional serotypes, serogroups, pool only and non vaccine serotypes (NVT) are presented with different shadow.</p
Antimicrobial susceptibility of the 280 isolates.
<p>Antimicrobial susceptibility of the 280 isolates.</p
Datasheet2_Joint statement for assessing and managing high blood pressure in children and adolescents: Chapter 1. how to correctly measure blood pressure in children and adolescents.pdf
The joint statement is a synergistic action between HyperChildNET and the European Academy of Pediatrics about the diagnosis and management of hypertension in youth, based on the European Society of Hypertension Guidelines published in 2016 with the aim to improve its implementation. The first and most important requirement for the diagnosis and management of hypertension is an accurate measurement of office blood pressure that is currently recommended for screening, diagnosis, and management of high blood pressure in children and adolescents. Blood pressure levels should be screened in all children starting from the age of 3 years. In those children with risk factors for high blood pressure, it should be measured at each medical visit and may start before the age of 3 years. Twenty-four-hour ambulatory blood pressure monitoring is increasingly recognized as an important source of information as it can detect alterations in circadian and short-term blood pressure variations and identify specific phenotypes such as nocturnal hypertension or non-dipping pattern, morning blood pressure surge, white coat and masked hypertension with prognostic significance. At present, home BP measurements are generally regarded as useful and complementary to office and 24-h ambulatory blood pressure for the evaluation of the effectiveness and safety of antihypertensive treatment and furthermore remains more accessible in primary care than 24-h ambulatory blood pressure. A grading system of the clinical evidence is included.</p
Datasheet1_Joint statement for assessing and managing high blood pressure in children and adolescents: Chapter 1. how to correctly measure blood pressure in children and adolescents.pdf
The joint statement is a synergistic action between HyperChildNET and the European Academy of Pediatrics about the diagnosis and management of hypertension in youth, based on the European Society of Hypertension Guidelines published in 2016 with the aim to improve its implementation. The first and most important requirement for the diagnosis and management of hypertension is an accurate measurement of office blood pressure that is currently recommended for screening, diagnosis, and management of high blood pressure in children and adolescents. Blood pressure levels should be screened in all children starting from the age of 3 years. In those children with risk factors for high blood pressure, it should be measured at each medical visit and may start before the age of 3 years. Twenty-four-hour ambulatory blood pressure monitoring is increasingly recognized as an important source of information as it can detect alterations in circadian and short-term blood pressure variations and identify specific phenotypes such as nocturnal hypertension or non-dipping pattern, morning blood pressure surge, white coat and masked hypertension with prognostic significance. At present, home BP measurements are generally regarded as useful and complementary to office and 24-h ambulatory blood pressure for the evaluation of the effectiveness and safety of antihypertensive treatment and furthermore remains more accessible in primary care than 24-h ambulatory blood pressure. A grading system of the clinical evidence is included.</p
Effect of clinician, workplace variables, and country of work on the use of POCTs in the clinical scenario (Model 5).
Effect of clinician, workplace variables, and country of work on the use of POCTs in the clinical scenario (Model 5).</p
Variation in the availability of POCTs between the included countries expressed as median odds ratio (MORs).
GAS: Group A streptococcus; RSV: Respiratory syncytial virus; FBC/WBC: Full blood count/White blood count; CRP: C-reactive protein; PCT: Procalcitonin. A: Country MORs for the availability of POCTs in primary care. B: Country MORs for the availability of POCTs in hospitals. MOR>1 indicate variation in the availability of POCTs across countries.</p